Stay updated with breaking news from Bryan Crowe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TARRYTOWN, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM, revenues increased 7%First quarter 2024 Dupixent® global net sales increased 24% to...
TARRYTOWN, N.Y., April 01, 2024 -- Regeneron Pharmaceuticals, Inc. today announced that it will report its first quarter 2024 financial and operating results on Thursday, May 2, 2024, before the...
TARRYTOWN, N.Y., Feb. 06, 2024 -- Regeneron Pharmaceuticals, Inc. will webcast management participation as follows: Oppenheimer 34th Annual Healthcare Life Sciences Conference at 1:20 p.m. ET on...